![Intellihealth Wins AmplifyHer Ventures Investment Competition at Weill Cornell Medicine - Intellihealth Intellihealth Wins AmplifyHer Ventures Investment Competition at Weill Cornell Medicine - Intellihealth](https://www.intellihealth.co/wp-content/uploads/2021/05/Winner-AmplifyHerVentures-Intellihealth-1.png)
Intellihealth Wins AmplifyHer Ventures Investment Competition at Weill Cornell Medicine - Intellihealth
![Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator – Bridge Medicines Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator – Bridge Medicines](https://bridgemedicines.com/wp-content/uploads/2020/11/post-eye-cornea.jpg)
Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator – Bridge Medicines
![Intellihealth Wins AmplifyHer Ventures Investment Competition at Weill Cornell Medicine - Intellihealth Intellihealth Wins AmplifyHer Ventures Investment Competition at Weill Cornell Medicine - Intellihealth](https://www.intellihealth.co/wp-content/uploads/2021/05/amplifyher-win-1024x683.jpeg)